Bio-Rad Laboratories Inc. (BIO) Tops Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $379.98 +0.70%
EPS Growth %: -1.3%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -1.3%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q2 EPS of $1.09, $0.14 better than the analyst estimate of $0.95. Revenue for the quarter came in at $536.8 million versus the consensus estimate of $537.58 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- CRH plc (CRH) PT Lowered to $135 at UBS, Buy Rating Maintained
- Exelon (EXC) PT Lowered to $49 at Argus
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
